On Monday, Shares of IHS Markit Ltd (NASDAQ:INFO), subtract -0.08% and closed at $37.52 in the last trading session. The last trading range of the stock ranges between $37.29 and $37.70. IHS Markit Ltd. (INFO), a global leader in critical information, analytics and solutions that drive economies and markets worldwide, recently stated results for the third quarter ended August 31, 2016. The following results include IHS results for the full three- and nine-month periods and Markit results from the date of merger (July 12, 2016) to August 31, 2016.
- Revenue of $725 million, up 30 percent from the prior-year period
- Total organic revenue declined 1 percent when normalized for BPVC timing; stated organic revenue declined 2 percent, with flat recurring organic revenue growth
- Net loss of $32 million and diluted earnings per share (EPS) of $(0.09), due mainly to merger-related costs
- Adjusted EBITDA of $269 million and Adjusted earnings per diluted share (Adjusted EPS) of $0.45
- Cash flow from operations of $147 million; free cash flow of $100 million
Adjusted EBITDA, Adjusted EPS, and free cash flow are non-GAAP financial measures used by administration to measure operating performance. These terms are defined elsewhere in this release. Please see plans appearing later in this release for reconciliations of non-GAAP financial measures to the most directly comparable GAAP measures.
Perrigo Company plc Ordinary Shares (NYSE:PRGO), jumped 1.57% and closed at $93.78 in the last trading session. The last trading range of the stock ranges between $91.26 and $93.89. The company’s Market capitalization is $13.23 Billion with the total Outstanding Shares of 143.28 million. Perrigo Company plc (NYSE: PRGO; TASE) recently declared an exclusive licensing agreement with Highland Pharmaceuticals, LLC for its Tarex® methamphetamine (“meth”) blocking technology and the distribution rights of Zephrex-D® (pseudoephedrine HCI 30 mg). Zephrex-D® was developed using the Tarex® technology and has been proven to be more than 98% effective at blocking one of the more common domestic methods of illegal meth production.
This agreement is part of Perrigo’s ongoing efforts in the fight against meth drug abuse. Perrigo plans to integrate the Tarex® technology into certain of its store brand and retailer own label pseudoephedrine HCI products in the future and will right away begin distribution of Zephrex D® to its retail customers.
Honeywell International Inc. (NYSE:HON), lost -0.46% and closed at $116.05 in the last trading session. The last trading range of the stock ranges between $114.89 and $116.29. During the 52-week trading session the minimum price at which share price traded, registered at $114.89 and reached to max level of $3,000.50. The U.S. Department of the Army has awarded a contract to the Advanced Turbine Engine Company (ATEC) – a joint venture of Honeywell and Pratt & Whitney – for the development and demonstration of advanced engine capabilities that could be applicable to a new fleet of future vertical lift combat helicopters.
The contract, part of the Army’s Alternate Concept Engine (ACE) program, is a science and technology effort intended to develop and validate new engine designs that will significantly improve vertical lift, range, speed, payload, survivability, and reliability for Army Aviation rotorcraft. Under the ACE program, ATEC will demonstrate advanced variable speed turbine capabilities in addition to other advanced technologies in a demonstrator engine test. In addition, the program is also focused on reducing operational and life cycle costs, and the logistical footprint for both the engine and future rotorcraft.
“We are excited to play such a noteworthyrole in meeting the needs of Army Aviation through our involvement in the ACE program,” said Craig Madden, president of ATEC. “We are focused on ensuring warfighter success by delivering state-of-the-art technology improvements for the Army’s future vertical lift platforms.”